The Wall Street Journal reported that Theranos Inc. secured a loan from Fortress Investment Group.
Valeant Pharmaceuticals is selling its Obagi Medical Products business to Haitong International Zhonghua Finance Acquisition Fund I for $190 million in cash.
Valeant Pharmaceuticals is selling off its equity interests in Dendreon Pharmaceuticals Inc. to China’s Sanpower Group Co. Ltd. for about $820 million.
London-listed pharma firm Shire said its dry-eye disease drug lifitegrast significantly improved patient symptoms in a new study, supporting a re-submission of the potentially block-busting medicine to U.S. regulators early next year. Shares in Shire jumped more than 6 percent after it announced the positive results of the study on Tuesday. They were trading up […]